Come see us at Flywheel 2025! Register Now »
The healthcare industry is experiencing an unprecedented transformation driven by artificial intelligence. Recent surveys show that 85% of healthcare leaders from payers, health systems, and healthcare services and technology groups were exploring or had already adopted generative AI capabilities.
The medical device industry has witnessed explosive growth in AI-enabled products, with the FDA authorizing nearly 1,000 medical devices with AI features in the last decade. AI is transforming every stage of product development, from initial concept to market launch. Organizations can use AI across the product lifecycle including generative design for medical devices, allowing for faster and more efficient design exploration, plus simulation and CAD capabilities. Machine learning algorithms can analyze vast datasets to identify unmet clinical needs, predict device performance under various conditions, and optimize designs for manufacturing efficiency.
However, this innovation remains concentrated among industry giants, largely represented by the biggest players, notably GE Healthcare and Siemens Healthineers. As of last year, GE Healthcare alone had 81 authorized AI devices. Johnson & Johnson is also making significant advances in leveraging AI to improve their technology and deliver better outcomes for doctors and patients.
But while attention has mostly focused on AI's clinical innovations and product development benefits, a critical opportunity remains underutilized: leveraging AI for commercial strategy and operational efficiency.
The strategic implementation of AI could be the difference between thriving and merely surviving in an increasingly competitive marketplace. Particularly for startups or growth-stage companies that need to do more with less.
Traditional relationship selling, a reliance on anecdotal evidence, and legacy CRMs leave significant information gaps in today's data-rich environment. Even the best commercial teams can miss high-value opportunities because there is simply too much market data to analyze manually.
Consider this practical example: nearly 10,000 physicians retire annually in the United States. Their procedure volume and product usage will transfer to other practitioners, creating substantial market opportunities. But exactly where will these procedures go? Would you rather have your sales reps spend weeks or months in the field trying to figure that out independently? Or would you prefer an AI-driven intelligence platform to provide that information in seconds?
AI-powered commercial platforms can analyze multiple data sources simultaneously - including claims data, physician networks, hospital affiliations, and historical purchasing patterns - to uncover data trends that predict where retiring physicians' patient volumes will likely transfer. This capability allows sales teams to proactively engage with likely beneficiaries of these volume shifts, ahead of the competition, rather than reacting when it may already be too late.
Much like in healthcare itself, the value of AI in MedTech sales isn't about replacing people. It's about making the people you have more productive and effective. Commercial leaders can use AI to analyze procedure data, market insights, and product fit to develop sophisticated go-to-market strategies. Sales reps can then use AI tools to prepare for meetings in seconds rather than spending hours or days researching key insights about a doctor or health system. Across the entire organization, AI makes teams more effective, more productive, and allows them to move faster
The medical device industry stands at an inflection point. While AI has already transformed product development and clinical applications, its potential for commercial transformation remains largely untapped. Companies that recognize this opportunity and act decisively will gain sustainable competitive advantages in a challenging market.
The data is clear, the technology is ready, and the opportunity is unprecedented. The only question remaining is whether companies will seize this moment to revamp their commercial strategies and secure their competitive advantage in the AI-driven healthcare landscape of tomorrow.
But MedTech success with AI will require more than just technology adoption. It will demand a fundamental reimagining of how companies engage with their markets, understand their customers, and deliver value throughout the healthcare ecosystem. The companies that make this transformation will lead the next chapter of healthcare innovation.
AcuityMD’s AI Call Plan and AI Executive Summary are already helping MedTech sales teams win more deals faster. Give us just 5 minutes and we’ll show you how we do it.
